A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
Status:
Not yet recruiting
Trial end date:
2023-11-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate long-term clinical response of JNJ-77242113
treatment in participants with moderate-to-severe plaque psoriasis.